Skip to main content
Premium Trial:

Request an Annual Quote

FDA to Use Rosetta s Resolver System for Data Submission Analysis

NEW YORK, Aug. 24 (GenomeWeb News) - The US Food and Drug Administration will use Rosetta Biosoftware's Rosetta Resolver system for genomic data management and analysis in order to analyze microarray data from sponsors, Rosetta said today.

According to Rosetta, the Center for Drug Evaluation and Research, an arm of the FDA, will use the system when evaluating genomic data submitted through the voluntary genomic data submissions program the agency initiated this year.

The system will be used to "understand, learn from, and reproduce analyses conducted by pharmaceutical companies who voluntarily submit genomics data," Rosetta said.

Financial details were not discussed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.